Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer

Pasquale F. Innominato, Sylvie Giacchetti, Georg A. Bjarnason, Christian Focan, Carlo Garufi, Bruno Coudert, Stefano Iacobelli, Marco Tampellini, Xavier Durando, Marie Christine Mormont, Jim Waterhouse, Francis A. Lévi

Research output: Contribution to journalArticle

Abstract

The clinical relevance of circadian rhythm modifications in patients on chemotherapy is unknown. Even so, circadian parameter I

Original languageEnglish
Pages (from-to)2684-2692
Number of pages9
JournalInternational Journal of Cancer
Volume131
Issue number11
DOIs
Publication statusPublished - Dec 1 2012

Keywords

  • actimetry
  • chronotherapy
  • circadian
  • colorectal cancer
  • rest-activity rhythm

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Innominato, P. F., Giacchetti, S., Bjarnason, G. A., Focan, C., Garufi, C., Coudert, B., Iacobelli, S., Tampellini, M., Durando, X., Mormont, M. C., Waterhouse, J., & Lévi, F. A. (2012). Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. International Journal of Cancer, 131(11), 2684-2692. https://doi.org/10.1002/ijc.27574